Current Ratio of Xilio Therapeutics, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Xilio Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Xilio Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 217%, a 4.4% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Xilio Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 217% +9.2% +4.4% 30 Sep 2025
Q2 2025 205% -47% -19% 30 Jun 2025
Q1 2025 194% -128% -40% 31 Mar 2025
Q4 2024 200% -241% -55% 31 Dec 2024
Q3 2024 208% -308% -60% 30 Sep 2024
Q2 2024 252% -376% -60% 30 Jun 2024
Q1 2024 322% -410% -56% 31 Mar 2024
Q4 2023 441% -458% -51% 31 Dec 2023
Q3 2023 517% -639% -55% 30 Sep 2023
Q2 2023 628% -544% -46% 30 Jun 2023
Q1 2023 732% 31 Mar 2023
Q4 2022 899% 31 Dec 2022
Q3 2022 1156% 30 Sep 2022
Q2 2022 1172% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.